Summary
Single-center oncology studies performed by dedicated PRA staff, combined with the High Precision QT approach of iCardiac, generates conclusive ECG data.
Register to download
ECG Assessments During the Development of Oncology Compounds
You may also be interested in:
Webcast
The Challenges of Patient Recruitment in Oncology Trials - Part 2
This is the second in a 3-part series on ”The Challenges of Patient Recruitment in Oncology Trials”, Senior Patient Recruitment Managers Tricia…
View Resource
Case Study
Optimal Recruitment Strategies
A mid-size, top 5 European pharmaceutical company engaged PRA in a global Phase III study in 20 countries on patients with advanced breast cancer…
View Resource
Blog
PRA Health Sciences and Deep Lens, Inc. partner to accelerate patient recruitment for precision cancer trials.
This strategic relationship brings together best-in-class technologies that improve the identification, screening, and matching of cancer patients to…
Read Story
View all related content and resources for Oncology
Explore Insights